LUTREPULSE KIT Drug Patent Profile
✉ Email this page to a colleague
When do Lutrepulse Kit patents expire, and what generic alternatives are available?
Lutrepulse Kit is a drug marketed by Ferring and is included in one NDA.
The generic ingredient in LUTREPULSE KIT is gonadorelin acetate. There are seven drug master file entries for this compound. Additional details are available on the gonadorelin acetate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LUTREPULSE KIT?
- What are the global sales for LUTREPULSE KIT?
- What is Average Wholesale Price for LUTREPULSE KIT?
Summary for LUTREPULSE KIT
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 12 |
Clinical Trials: | 4 |
DailyMed Link: | LUTREPULSE KIT at DailyMed |
Recent Clinical Trials for LUTREPULSE KIT
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | Early Phase 1 |
Los Angeles Biomedical Research Institute | Early Phase 1 |
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | Phase 1 |
US Patents and Regulatory Information for LUTREPULSE KIT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ferring | LUTREPULSE KIT | gonadorelin acetate | INJECTABLE;INJECTION | 019687-001 | Oct 10, 1989 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Ferring | LUTREPULSE KIT | gonadorelin acetate | INJECTABLE;INJECTION | 019687-002 | Oct 10, 1989 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |